The views & opinions expressed are those of the contributing authors and editors and do not necessarily represent the views of the ACC. More
Article of the Month
Drs. Paul Gurbel and Udaya Tantry review platelet activity and clopidogrel therapy.
A 52-old-man has demographic variables associated with clopidogrel resistance (morbid obesity, diabetes, non-smoking status) and is now to undergo multivessel, and possibly three-vessel, stenting. Would you perform platelet function testing on this high-risk patient?